Latest Biotech News

Ginkgo Bioworks secured a BARDA BioMaP contract worth up to $22.2 million to develop cost‑reducing, rapid domestic manufacturing for monoclonal antibodies against filoviruses, including Ebola and...

Hepta Bio, founded by former Illumina and Grail staff, closed a $6.7 million seed financing to develop transformer‑based AI that decodes cfDNA methylation signals to detect chronic diseases such...

Moderna reported a sharp drop in vaccine sales and signaled further cost discipline to stabilize finances, saying it expects to break even by 2028 through spending controls and pipeline...

Novo Nordisk raised its offer for obesity biotech Metsera as a rival bid from Pfizer intensified and U.S. antitrust officials publicly flagged the proposed transaction structure. Sources told...

The U.S. Food and Drug Administration issued a complete response letter for Biohaven’s troriluzole in spinocerebellar ataxia, and the company immediately moved to cut annual research spending by...

Eli Lilly reported phase 2 data showing its amylin receptor agonist eloralintide produced dose‑dependent weight loss—up to 20.1% at Week 48—and said it will move the program into Phase 3. The...

A Nature paper showed RFdiffusion and allied hypermutation systems can design de novo single‑domain antibodies that bind user‑specified epitopes with atomically accurate poses, and structural work...

Hepta Bio, a startup founded by former Illumina and Grail scientists, closed a $6.7 million seed round to develop transformer‑based AI that interprets cell‑free DNA methylation for chronic disease...

Ginkgo Bioworks secured a Biopharmaceutical Manufacturing Preparedness Consortium contract through BARDA worth up to $22.2 million to develop cost‑reducing, scalable manufacturing approaches for...

Johnson & Johnson’s Caplyta gained FDA approval as an adjunctive treatment for major depressive disorder, expanding the label after J&J acquired the asset via its Intra‑Cellular Therapies...

Researchers reported that inhibiting PIM3 kinase reverses CAR‑T cell dysfunction induced by hypoxia within solid tumor microenvironments, restoring cytotoxic activity in preclinical models. The...

AmacaThera signed a licensing and collaboration agreement with Pacira BioSciences worth up to $230 million for AMT‑143, a hydrogel‑based long‑acting ropivacaine designed for extended...

A Phase I study of an adjuvanted, intranasal recombinant influenza A/H5 vaccine demonstrated broad priming of immune responses across multiple H5 clades, suggesting a mucosal route could provide...

Researchers have demonstrated de novo antibody design with atomic-level accuracy using RFdiffusion and an integrated hypermutation system, validating binding poses by cryo-electron microscopy. The...

The U.S. Food and Drug Administration issued a complete response letter rejecting Biohaven’s New Drug Application for troriluzole in spinocerebellar ataxia, citing concerns about real‑world...

Federal Trade Commission staff warned that Novo Nordisk’s proposed deal structure for a takeover of obesity biotech Metsera may violate the Hart‑Scott‑Rodino premerger review process, raising...

Eli Lilly said its experimental amylin receptor agonist eloralintide met predefined efficacy thresholds and will advance into Phase 3 testing after phase 2 results showing up to 20.1% weight loss...

Hepta Bio, founded by veterans of Illumina and Grail, closed a $6.7 million seed round led by Felicis Ventures and Illumina Ventures to commercialize a transformer‑based AI that reads the...

Researchers unveiled CRISPR PRO‑LiveFISH, a multiplexed live‑cell imaging approach that visualizes chromatin dynamics and promoter–enhancer interactions at multiple non‑repetitive loci. Published...

China’s Ministry of Commerce announced it will lift the export ban on Illumina sequencing systems on November 10, reversing restrictions imposed earlier this year and reopening a critical market...